Cover Image
市場調查報告書

暗瘡藥:契約條件·協定內容

Global Acne Partnering 2010 to 2016

出版商 Current Partnering, a division of Wildwood Ventures Limited 商品編碼 268578
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
暗瘡藥:契約條件·協定內容 Global Acne Partnering 2010 to 2016
出版日期: 2016年09月01日 內容資訊: 英文
簡介

本報告提供暗瘡藥相關的各種合作契約趨勢調查分析,提供大製藥公司的各種合作概要,契約區分·產業部門·開發階段·各技術區分契約資料的目錄等彙整資料,為您概述為以下內容。

摘要整理

第1章 簡介

第2章 暗瘡藥相關的各種合作趨勢

  • 簡介
  • 常年的暗瘡藥合作
  • 大型製藥企業的暗瘡藥契約活動
  • 暗瘡藥合作:各類型契約
  • 暗瘡藥合作:各產品部門
  • 暗瘡藥合作:各開發階段
  • 暗瘡藥合作:各技術類型
  • 暗瘡藥合作被公開的契約條件

第3章 主要暗瘡藥合作:契約

  • 簡介
  • 主要契約:各金額
  • 主要契約相關的大型製藥企業

第4章 契約目錄

  • 簡介
  • 不同企業(A-Z)
  • 各類型契約
    • 資產購買
    • 大醫藥品企業的對外授權
    • 共同開發
    • 共同R&D
    • 共同行銷
    • 業務委託
    • 共同促銷
    • CRADA
    • 交叉授權
    • 開發
    • 流通銷售等
  • 各產品部門
    • 大學
    • 大型製藥企業
    • 生物科技
    • 給藥
    • 醫療設備
    • 診斷
    • 學名藥企業
    • 政府
    • 非營利團體
    • 醫藥品企業
    • 調查工具
    • 服務
    • 特殊藥企業
  • 各開發階段
    • 藥物研發
    • 前臨床
    • 第一階段
    • 第二階段
    • 第三階段
    • 申請登記
    • 上市
  • 各技術類型
    • 分析
    • 動物模式
    • 化驗
    • 生物資訊
    • 生物化合物
    • 生物標記
    • 生醫材料
    • 細胞培養
    • 細胞治療
    • 臨床實驗
    • 診斷-陪伴員
    • 設備
    • 診斷
    • 藥物研發工具
    • (DNA)核酸探針
    • 給藥
    • 實現技術
    • 表觀遺傳學
    • 設備
    • 設施
    • 基因治療
    • 基因學
    • 成像
    • 工業化學物質
    • 體外模式
    • 單株抗體
    • 奈米技術
    • oligo核?酸
    • 胜肽
    • 定制醫療
    • 加工
    • 蛋白質體學
    • 放射線/化療
    • 重組的DNA
    • 研究服務
    • 研究用品
    • RNA治療
    • 篩檢
    • 小分子
    • 幹細胞
    • 疫苗

第5章 合作資源中心

  • 網路夥伴合作
  • 合作夥伴活動
  • 參考資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: CP2216ane

Provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare companies .

The ‘Global Therapy Partnering Terms and Agreements since 2010’ report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

  • Trends in partnering deals
  • Top deals by value
  • Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual bladder cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Benefits

‘Global Therapy Partnering Terms and Agreements since 2010’ report provides the reader with the following key benefits:

  • In-depth understanding of deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Comprehensive access to multiple deals entered into by the world's biopharma companies since 2010
  • Insight into key deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed in deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Table of Contents

Executive Summary

Chapter 1 - Therapypartnering trends in numbers

  • Partnering in numbers - by year
  • Partnering in numbers - most active
  • Partnering in numbers - by industry sector
  • Partnering in numbers - by deal type
  • Partnering in numbers - by technology type
  • Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory

  • Partnering deals directory - by company A-Z
  • Partnering deals directory - by deal value
  • Partnering deals directory - by industry sector
  • Partnering deals directory - by deal type
  • Partnering deals directory - by stage of development
  • Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document

Chapter 5 - M&A in numbers

  • M&A in numbers - by year

Chapter 6 - M&A deals directory

  • M&A deals directory - by company A-Z
  • M&A deals directory - by deal value

Chapter 7 - Financing in numbers

  • Financing in numbers - by year
  • Financing in numbers - by financing type

Chapter 8 - Financing deals directory

  • Financing deals directory - by company A-Z
  • Financing deals directory - by deal value
  • Financing deals directory - by financing type

About Wildwood Ventures

  • Current Partnering
  • Current Agreements
  • Recent titles from CurrentPartnering

TABLE OF FIGURES

  • Figure 1: Partnering frequency by year
  • Figure 2: Partnering most active
  • Figure 3: Partnering by industry sector
  • Figure 4: Partnering by deal type
  • Figure 5: Partnering by technology area
  • Figure 6: Partnering by stage of development
  • Figure 7: M&A frequency by year
  • Figure 8: Financing frequency by year
  • Figure 9: Financing by type
Back to Top